Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-14-000318
Filing Date
2014-11-13
Accepted
2014-11-12 17:42:48
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 sangui_10qsep2014110714vedga.htm 10-Q 360129
2 exhibit3101vedgar1.htm EX-31 10589
3 exhibit3102vedgar1.htm EX-31 10747
4 exhibit3201vedgar1.htm EX-32 9012
  Complete submission text file 0001551163-14-000318.txt   1129669

Data Files

Seq Description Document Type Size
5 sgbi-20140930.xml EX-101.INS 45485
6 sgbi-20140930.xsd EX-101.SCH 12242
7 sgbi-20140930_cal.xml EX-101.CAL 13958
8 sgbi-20140930_def.xml EX-101.DEF 9024
9 sgbi-20140930_lab.xml EX-101.LAB 73279
10 sgbi-20140930_pre.xml EX-101.PRE 60434
Mailing Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025
Business Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025 011 49 1607 412717
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

EIN.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 141215474
SIC: 2834 Pharmaceutical Preparations